pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Study finds blocking T cells entry into brain slows neurodegeneration in mice

Sep 29, 2026·read at STAT ↗Positive

Researchers at Washington University in St. Louis reported that preventing certain immune cells, specifically T cells, from entering the brain reduced signs of neurodegeneration in a mouse model.

The team used genetic and pharmacologic methods to limit T‑cell infiltration and observed slower loss of neurons compared with untreated mice.

These findings suggest that T‑cell activity in the brain may play a role in neurodegenerative processes and could represent a new therapeutic avenue, although further studies in humans are needed.

The study adds to growing evidence that the immune system interacts with brain health, highlighting potential targets for future drug development.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Researchers slow neurodegeneration in mice by barring T cells from the brain”

read at STAT ↗
1,332 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING2
topics
Immunology6Infectious Disease2Vaccine2Vaccines2CRISPR/Cas9Major DepressionMonoclonal AntibodyPsychiatry & CNS

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 6d agoNovo workforce down 13,000BioSpace
  • Aug 31A winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Sling reels in $123M; Circle gathers $92.5MFierce Biotech
  • Sep 14After a brief storm of political headwinds, mRNA is back with strong momentumBioSpace